Advanced Instruments Revenue

About Advanced Instruments

Advanced Instruments has merged with Nova Biomedical, uniting two innovation-driven organizations to form a larger, global life science tools company operating under the Nova Biomedical name. This strategic combination broadens our expertise in bioprocessing and clinical diagnostics, strengthening our capacity to serve customers and create lasting impact across the life sciences and healthcare industries. You will see branding changes with our official name change transition happening in the fall. Our focus on service, quality, and reliability has made Advanced Instruments a leading developer and manufacturer of analytical instruments and services for the biopharmaceutical, clinical, and food & beverage industries for over 70 years. We provide innovative technologies aligned with the needs of the markets we serve, helping to improve efficiency, enhance productivity, and ensure best-in-class performance. Our Solentim portfolio of imaging and single-cell deposition technologies enables the clonal isolation, outgrowth, and characterization of high-value cells for monoclonal antibody development and cell and gene therapy. Our micro-osmometers are built for biotech and integrate into GMP and non-GMP workflows to ensure yield, quality, and purity. Clinical labs worldwide rely on our solutions for chemistry, microbiology, and hematology to deliver accurate, timely results and streamline workflows. Our Artel portfolio includes instruments, software, and services that validate, automate, and calibrate critical liquid handling processes. We are supported by a global network of direct sales and distributors, with 24/7 technical support. Interested in joining a dynamic team? Let’s connect. For more information, visit www.aicompanies.com.

View contact profiles from Advanced Instruments